Mealey's (February 7, 2018, 11:43 AM EST) -- WASHINGTON, D.C. — In a Feb. 6 decision, the Federal Circuit U.S. Court of Appeals agreed with a Delaware federal judge that two patents relating to the injectable bivalirudin drug Angiomax...
On Remand From En Banc Court, Federal Circuit Panel Affirms Noninfringement Ruling
To view the full article, register now.
Try for FREE for fourteen days
Already a subscriber? Click here to login